MarginsXMarginsX
Home › Markets › Health Care › GH

Guardant Health Inc. (GH)

GH trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$144.03
-5.06% on the day
Market cap
$19.5B
Large cap
Revenue · 2025
$982.0M
+32.9% on 2024
Net income · 2025
-$416.3M
-42.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/0001576280-26-000013-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerGH on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO year2018
SEC CIK0001576280
SEC industry codeServices-Medical Laboratories
Incorporated inDE

Financials · 2025

LineValue
Revenue$982.0M
Net income-$416.3M
Operating income-$437.2M
Net margin-42.4%
Operating margin-44.5%
Revenue growth+32.9%
Cash$378.2M
Total assets$2.0B
P/E (computed)Net income was not positive
P/S (computed)19.8×

Warning signs

Cash runway
71.0 months
$1.0B cash at September 30, 2026
Share count, 1 year
+7.3%
2025-10-24 to 2026-10-30 · +14.7% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
-$168.6M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$1.0B cash; operating cash flow -$43.4M a quarter.Report 2026-09-30
Shares outstanding135,285,975 (2026-10-30); 126,041,089 a year earlier; 117,992,240 three years earlier.Cover page 2026-10-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-07-30
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, San Jose, California, United StatesPCAOB Form AP 2026-03-12
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $78K, sold $168.7M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$361.0M-$124.4M-$23.7M$1.0B$1.5B$1.3B10-Q 2026-11-05
Q2 2026
2026-06-30
$335.0M-$120.1M-$57.8M$1.1B$1.5B$1.2B10-Q 2026-07-30
Q1 2026
2026-03-31
$301.7M-$112.1M-$65.6M$989.3M$1.5B$1.1B10-Q 2026-05-07
Q4 2025
2025-12-31
$281.3M-$128.5M-$26.4M$378.2M$1.5B$982.0M10-K 2026-02-19
Q3 2025
2025-09-30
$265.2M-$92.7M-$35.4M$580.0M$1.1B$902.6M10-Q 2026-11-05
Q2 2025
2025-06-30
$232.1M-$99.9M-$60.3M$629.1M$1.1B$828.8M10-Q 2026-07-30
Q1 2025
2025-03-31
$203.5M-$95.2M-$62.7M$698.6M$1.1B$774.0M10-Q 2026-05-07
Q4 2024
2024-12-31
$201.8M-$111.0M-$64.5M$525.5M$1.1B$739.0M10-K 2026-02-19

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2026-07-30
Latest annual report10-K2026-02-19
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-16
Latest proxyDEFA14A2026-04-28

Source: SEC EDGAR submissions feed, 1,004 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.6%
1 month-6.4%
3 months-4.9%
Year to date+48.5%
1 year+61.2%
From 52-week high-19.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
DGXQuest Diagnostics Incorporated$262.21+1.01%$28.8B
ILMNIllumina Inc.$198.00-4.35%$29.9B
LHLabcorp Holdings Inc.$372.46+0.53%$30.2B
MOHMolina Healthcare Inc$233.09+11.27%$12.2B
CNCCentene Corporation$74.77+4.91%$37.0B
OSCROscar Health Inc.$31.33+0.90%$9.7B
HSICHenry Schein Inc.$84.96-1.46%$9.4B
NTRANatera Inc.$288.48-9.59%$41.8B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier